Real-time enrollment status for this catecholaminergic polymorphic ventricular tachycardia clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 3:46 PM UTC
| NCT Number | NCT06658899 |
| Recruiting Status | Recruiting |
| Condition | Catecholaminergic Polymorphic Ventricular Tachycardia |
| Phase | Clinical Trial |
| Target Enrollment | 12 participants |
| Active Locations | 5 sites in the US |
| Sponsor | Cardurion Pharmaceuticals, Inc. |
| Last Updated on CT.gov | July 9, 2026 (4 days ago) |
As of July 13, 2026: Clinical trial NCT06658899 is currently recruiting participants. This clinical trial study for catecholaminergic polymorphic ventricular tachycardia is actively seeking new participants at 5 locations across the United States. The study is sponsored by Cardurion Pharmaceuticals, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06658899 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06658899 was last updated 4 days ago (July 9, 2026). HelloStudys verifies this status automatically.